Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge.
Sulfidopeptide leukotrienes have been implicated in the pathogenesis of asthma because of their ability to induce bronchospasm, airways hyperreactivity, and increased mucus production. In the present study, the leukotrienes (LT) C4, D4, and E4 were measured in bronchoalveolar lavage fluid (BALF) before and 5 min after endobronchial allergen challenge in four subject groups: nonatopic nonasthmatic, nonatopic asthmatic, atopic nonasthmatic, and atopic asthmatic. As determined by high performance liquid chromatography (HPLC), after allergen challenge, the predominant sulfidopeptide leukotriene found in BALF from atopic asthmatics was LTC4. Smaller amounts of LTD4 and LTE4 were detectable. The baseline level of leukotrienes in the atopic asthmatics was 64 +/- 18 pg/ml, with measurable levels being found in nine of 11 samples. Atopic nonasthmatics had measurable levels in only one of seven baseline samples, whereas five of six nonatopic subjects had undetectable levels. Allergen challenge in atopic asthmatics resulted in significant increases in LTC4 over prechallenge levels (64 +/- 18 to 616 +/- 193 pg/ml) (p less than 0.01) and over levels in the three control groups after challenge (p = 0.0297). The atopic nonasthmatic group also had detectable leukotriene levels after allergen challenge (88 +/- 32 pg/ml), whereas leukotrienes remained undetectable in five of the six nonatopic samples. For comparison, histamine and the prostanoids prostaglandin D2 (PGD2) and thromboxane B2 (TxB2) were also measured in BALF. The levels of all three of these mediators increased in BALF from atopic asthmatics after allergen challenge. After allergen challenge, the best correlation was found between the levels in BALF for the prostanoids PGD2 and TxB2 (r = 0.88).(ABSTRACT TRUNCATED AT 250 WORDS)
Wenzel
S E
SE
Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.
Larsen
G L
GL
Johnston
K
K
Voelkel
N F
NF
Westcott
J Y
JY
D000328:Adult; D000485:Allergens; D001249:Asthma / Q000175:diagnosis*; D001985:Bronchial Provocation Tests; D001992:Bronchoalveolar Lavage Fluid / Q000032:analysis*; D005260:Female; D006632:Histamine / Q000032:analysis; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000175:diagnosis*; D007124:Immunoenzyme Techniques; D008297:Male; D011453:Prostaglandins / Q000032:analysis; D013189:SRS-A / Q000032:analysis*; D013997:Time Factors
D000485:Allergens; D011453:Prostaglandins; D013189:SRS-A; D006632:Histamine